HEADER TRANSFERASE/TRANSFERASE INHIBITOR 22-MAY-14 4PMM
TITLE THE STRUCTURE OF TRKA KINASE BOUND TO THE INHIBITOR N-(3-CYCLOPROPYL-
TITLE 2 1-PHENYL-1H-PYRAZOL-5-YL)-2-{4-[3-METHOXY-4-(4-METHYL-1H-IMIDAZOL-1-
TITLE 3 YL)PHENYL]-1H-1,2,3-TRIAZOL-1-YL}ACETAMIDE
COMPND MOL_ID: 1;
COMPND 2 MOLECULE: HIGH AFFINITY NERVE GROWTH FACTOR RECEPTOR;
COMPND 3 CHAIN: A;
COMPND 4 FRAGMENT: KINASE DOMAIN (UNP RESIDUES 501-787);
COMPND 5 SYNONYM: NEUROTROPHIC TYROSINE KINASE RECEPTOR TYPE 1,TRK1-
COMPND 6 TRANSFORMING TYROSINE KINASE PROTEIN,TROPOMYOSIN-RELATED KINASE A,
COMPND 7 TYROSINE KINASE RECEPTOR,TYROSINE KINASE RECEPTOR A,TRK-A,GP140TRK,
COMPND 8 P140-TRKA;
COMPND 9 EC: 2.7.10.1;
COMPND 10 ENGINEERED: YES
SOURCE MOL_ID: 1;
SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS;
SOURCE 3 ORGANISM_COMMON: HUMAN;
SOURCE 4 ORGANISM_TAXID: 9606;
SOURCE 5 GENE: NTRK1, MTC, TRK, TRKA;
SOURCE 6 EXPRESSION_SYSTEM: SPODOPTERA FRUGIPERDA;
SOURCE 7 EXPRESSION_SYSTEM_TAXID: 7108
KEYWDS KINASE, TRANSFERASE-TRANSFERASE INHIBITOR COMPLEX
EXPDTA X-RAY DIFFRACTION
AUTHOR H.P.SU
REVDAT 4 27-DEC-23 4PMM 1 SOURCE JRNL REMARK
REVDAT 3 25-FEB-15 4PMM 1 REMARK
REVDAT 2 01-OCT-14 4PMM 1 JRNL
REVDAT 1 18-JUN-14 4PMM 0
JRNL AUTH S.J.STACHEL,J.M.SANDERS,D.A.HENZE,M.T.RUDD,H.P.SU,Y.LI,
JRNL AUTH 2 K.K.NANDA,M.S.EGBERTSON,P.J.MANLEY,K.L.JONES,E.J.BRNARDIC,
JRNL AUTH 3 A.GREEN,J.A.GROBLER,B.HANNEY,M.LEITL,M.T.LAI,V.MUNSHI,
JRNL AUTH 4 D.MURPHY,K.RICKERT,D.RILEY,A.KRASOWSKA-ZOLADEK,C.DALEY,
JRNL AUTH 5 P.ZUCK,S.A.KANE,M.T.BILODEAU
JRNL TITL MAXIMIZING DIVERSITY FROM A KINASE SCREEN: IDENTIFICATION OF
JRNL TITL 2 NOVEL AND SELECTIVE PAN-TRK INHIBITORS FOR CHRONIC PAIN.
JRNL REF J.MED.CHEM. V. 57 5800 2014
JRNL REFN ISSN 0022-2623
JRNL PMID 24914455
JRNL DOI 10.1021/JM5006429
REMARK 2
REMARK 2 RESOLUTION. 2.00 ANGSTROMS.
REMARK 3
REMARK 3 REFINEMENT.
REMARK 3 PROGRAM : BUSTER 2.11.5
REMARK 3 AUTHORS : BRICOGNE,BLANC,BRANDL,FLENSBURG,KELLER,
REMARK 3 : PACIOREK,ROVERSI,SHARFF,SMART,VONRHEIN,
REMARK 3 : WOMACK,MATTHEWS,TEN EYCK,TRONRUD
REMARK 3
REMARK 3 DATA USED IN REFINEMENT.
REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.00
REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 22.96
REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000
REMARK 3 COMPLETENESS FOR RANGE (%) : 99.9
REMARK 3 NUMBER OF REFLECTIONS : 24653
REMARK 3
REMARK 3 FIT TO DATA USED IN REFINEMENT.
REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT
REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM
REMARK 3 R VALUE (WORKING + TEST SET) : 0.166
REMARK 3 R VALUE (WORKING SET) : 0.165
REMARK 3 FREE R VALUE : 0.199
REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.010
REMARK 3 FREE R VALUE TEST SET COUNT : 1234
REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL
REMARK 3
REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN.
REMARK 3 TOTAL NUMBER OF BINS USED : 12
REMARK 3 BIN RESOLUTION RANGE HIGH (ANGSTROMS) : 2.00
REMARK 3 BIN RESOLUTION RANGE LOW (ANGSTROMS) : 2.09
REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 99.85
REMARK 3 REFLECTIONS IN BIN (WORKING + TEST SET) : 3003
REMARK 3 BIN R VALUE (WORKING + TEST SET) : 0.1734
REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 2853
REMARK 3 BIN R VALUE (WORKING SET) : 0.1715
REMARK 3 BIN FREE R VALUE : 0.2146
REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 5.00
REMARK 3 BIN FREE R VALUE TEST SET COUNT : 150
REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL
REMARK 3
REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT.
REMARK 3 PROTEIN ATOMS : 2258
REMARK 3 NUCLEIC ACID ATOMS : 0
REMARK 3 HETEROGEN ATOMS : 56
REMARK 3 SOLVENT ATOMS : 146
REMARK 3
REMARK 3 B VALUES.
REMARK 3 FROM WILSON PLOT (A**2) : 27.05
REMARK 3 MEAN B VALUE (OVERALL, A**2) : 32.72
REMARK 3 OVERALL ANISOTROPIC B VALUE.
REMARK 3 B11 (A**2) : -2.21820
REMARK 3 B22 (A**2) : -2.21820
REMARK 3 B33 (A**2) : 4.43650
REMARK 3 B12 (A**2) : 0.00000
REMARK 3 B13 (A**2) : 0.00000
REMARK 3 B23 (A**2) : 0.00000
REMARK 3
REMARK 3 ESTIMATED COORDINATE ERROR.
REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.177
REMARK 3 DPI (BLOW EQ-10) BASED ON R VALUE (A) : 0.133
REMARK 3 DPI (BLOW EQ-9) BASED ON FREE R VALUE (A) : 0.124
REMARK 3 DPI (CRUICKSHANK) BASED ON R VALUE (A) : 0.134
REMARK 3 DPI (CRUICKSHANK) BASED ON FREE R VALUE (A) : 0.126
REMARK 3
REMARK 3 REFERENCES: BLOW, D. (2002) ACTA CRYST D58, 792-797
REMARK 3 CRUICKSHANK, D.W.J. (1999) ACTA CRYST D55, 583-601
REMARK 3
REMARK 3 CORRELATION COEFFICIENTS.
REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.953
REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.937
REMARK 3
REMARK 3 NUMBER OF GEOMETRIC FUNCTION TERMS DEFINED : 15
REMARK 3 TERM COUNT WEIGHT FUNCTION.
REMARK 3 BOND LENGTHS : 2377 ; 2.000 ; HARMONIC
REMARK 3 BOND ANGLES : 3217 ; 2.000 ; HARMONIC
REMARK 3 TORSION ANGLES : 811 ; 2.000 ; SINUSOIDAL
REMARK 3 TRIGONAL CARBON PLANES : 49 ; 8.000 ; HARMONIC
REMARK 3 GENERAL PLANES : 388 ; 8.000 ; HARMONIC
REMARK 3 ISOTROPIC THERMAL FACTORS : 2377 ; 20.000 ; HARMONIC
REMARK 3 BAD NON-BONDED CONTACTS : NULL ; NULL ; NULL
REMARK 3 IMPROPER TORSIONS : NULL ; NULL ; NULL
REMARK 3 PSEUDOROTATION ANGLES : NULL ; NULL ; NULL
REMARK 3 CHIRAL IMPROPER TORSION : 284 ; 5.000 ; SEMIHARMONIC
REMARK 3 SUM OF OCCUPANCIES : NULL ; NULL ; NULL
REMARK 3 UTILITY DISTANCES : NULL ; NULL ; NULL
REMARK 3 UTILITY ANGLES : NULL ; NULL ; NULL
REMARK 3 UTILITY TORSION : NULL ; NULL ; NULL
REMARK 3 IDEAL-DIST CONTACT TERM : 2826 ; 4.000 ; SEMIHARMONIC
REMARK 3
REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES.
REMARK 3 BOND LENGTHS (A) : 0.010
REMARK 3 BOND ANGLES (DEGREES) : 1.00
REMARK 3 PEPTIDE OMEGA TORSION ANGLES (DEGREES) : 2.55
REMARK 3 OTHER TORSION ANGLES (DEGREES) : 17.11
REMARK 3
REMARK 3 TLS DETAILS
REMARK 3 NUMBER OF TLS GROUPS : NULL
REMARK 3
REMARK 3 OTHER REFINEMENT REMARKS: NULL
REMARK 4
REMARK 4 4PMM COMPLIES WITH FORMAT V. 3.30, 13-JUL-11
REMARK 100
REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 23-MAY-14.
REMARK 100 THE DEPOSITION ID IS D_1000201706.
REMARK 200
REMARK 200 EXPERIMENTAL DETAILS
REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION
REMARK 200 DATE OF DATA COLLECTION : 09-APR-10
REMARK 200 TEMPERATURE (KELVIN) : 100
REMARK 200 PH : 6.5
REMARK 200 NUMBER OF CRYSTALS USED : 1
REMARK 200
REMARK 200 SYNCHROTRON (Y/N) : Y
REMARK 200 RADIATION SOURCE : APS
REMARK 200 BEAMLINE : 17-ID
REMARK 200 X-RAY GENERATOR MODEL : NULL
REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M
REMARK 200 WAVELENGTH OR RANGE (A) : 1.0
REMARK 200 MONOCHROMATOR : NULL
REMARK 200 OPTICS : NULL
REMARK 200
REMARK 200 DETECTOR TYPE : CCD
REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 210
REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS
REMARK 200 DATA SCALING SOFTWARE : AIMLESS
REMARK 200
REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 28795
REMARK 200 RESOLUTION RANGE HIGH (A) : 2.000
REMARK 200 RESOLUTION RANGE LOW (A) : 56.680
REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL
REMARK 200
REMARK 200 OVERALL.
REMARK 200 COMPLETENESS FOR RANGE (%) : 99.2
REMARK 200 DATA REDUNDANCY : 5.600
REMARK 200 R MERGE (I) : 0.08600
REMARK 200 R SYM (I) : 0.08600
REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 14.6000
REMARK 200
REMARK 200 IN THE HIGHEST RESOLUTION SHELL.
REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : NULL
REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : NULL
REMARK 200 COMPLETENESS FOR SHELL (%) : NULL
REMARK 200 DATA REDUNDANCY IN SHELL : NULL
REMARK 200 R MERGE FOR SHELL (I) : NULL
REMARK 200 R SYM FOR SHELL (I) : NULL
REMARK 200 <I/SIGMA(I)> FOR SHELL : NULL
REMARK 200
REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH
REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: FOURIER SYNTHESIS
REMARK 200 SOFTWARE USED: NULL
REMARK 200 STARTING MODEL: NULL
REMARK 200
REMARK 200 REMARK: NULL
REMARK 280
REMARK 280 CRYSTAL
REMARK 280 SOLVENT CONTENT, VS (%): 56.13
REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.80
REMARK 280
REMARK 280 CRYSTALLIZATION CONDITIONS: 0.1M BIS-TRIS, 2.3M AMMONIUMACETATE,
REMARK 280 PH 6.5, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 277K
REMARK 290
REMARK 290 CRYSTALLOGRAPHIC SYMMETRY
REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 64
REMARK 290
REMARK 290 SYMOP SYMMETRY
REMARK 290 NNNMMM OPERATOR
REMARK 290 1555 X,Y,Z
REMARK 290 2555 -Y,X-Y,Z+1/3
REMARK 290 3555 -X+Y,-X,Z+2/3
REMARK 290 4555 -X,-Y,Z
REMARK 290 5555 Y,-X+Y,Z+1/3
REMARK 290 6555 X-Y,X,Z+2/3
REMARK 290
REMARK 290 WHERE NNN -> OPERATOR NUMBER
REMARK 290 MMM -> TRANSLATION VECTOR
REMARK 290
REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS
REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM
REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY
REMARK 290 RELATED MOLECULES.
REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000
REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000
REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000
REMARK 290 SMTRY1 2 -0.500000 -0.866025 0.000000 0.00000
REMARK 290 SMTRY2 2 0.866025 -0.500000 0.000000 0.00000
REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 37.44667
REMARK 290 SMTRY1 3 -0.500000 0.866025 0.000000 0.00000
REMARK 290 SMTRY2 3 -0.866025 -0.500000 0.000000 0.00000
REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 74.89333
REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 0.00000
REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 0.00000
REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 0.00000
REMARK 290 SMTRY1 5 0.500000 0.866025 0.000000 0.00000
REMARK 290 SMTRY2 5 -0.866025 0.500000 0.000000 0.00000
REMARK 290 SMTRY3 5 0.000000 0.000000 1.000000 37.44667
REMARK 290 SMTRY1 6 0.500000 -0.866025 0.000000 0.00000
REMARK 290 SMTRY2 6 0.866025 0.500000 0.000000 0.00000
REMARK 290 SMTRY3 6 0.000000 0.000000 1.000000 74.89333
REMARK 290
REMARK 290 REMARK: NULL
REMARK 300
REMARK 300 BIOMOLECULE: 1
REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM
REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN
REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON
REMARK 300 BURIED SURFACE AREA.
REMARK 350
REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN
REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE
REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS
REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND
REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN.
REMARK 350
REMARK 350 BIOMOLECULE: 1
REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC
REMARK 350 APPLY THE FOLLOWING TO CHAINS: A
REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000
REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000
REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000
REMARK 375
REMARK 375 SPECIAL POSITION
REMARK 375 THE FOLLOWING ATOMS ARE FOUND TO BE WITHIN 0.15 ANGSTROMS
REMARK 375 OF A SYMMETRY RELATED ATOM AND ARE ASSUMED TO BE ON SPECIAL
REMARK 375 POSITIONS.
REMARK 375
REMARK 375 ATOM RES CSSEQI
REMARK 375 CL CL A 803 LIES ON A SPECIAL POSITION.
REMARK 375 HOH A 906 LIES ON A SPECIAL POSITION.
REMARK 465
REMARK 465 MISSING RESIDUES
REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE
REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN
REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.)
REMARK 465
REMARK 465 M RES C SSSEQI
REMARK 465 PRO A 534
REMARK 465 GLU A 535
REMARK 465 GLN A 536
REMARK 465 ALA A 549
REMARK 465 SER A 550
REMARK 465 GLU A 551
REMARK 470
REMARK 470 MISSING ATOM
REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER;
REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER;
REMARK 470 I=INSERTION CODE):
REMARK 470 M RES CSSEQI ATOMS
REMARK 470 LYS A 538 CG CD CE NZ
REMARK 470 ARG A 554 CG CD NE CZ NH1 NH2
REMARK 470 GLN A 570 CG CD OE1 NE2
REMARK 470 ARG A 583 CG CD NE CZ NH1 NH2
REMARK 470 ARG A 682 CG CD NE CZ NH1 NH2
REMARK 470 ARG A 686 CG CD NE CZ NH1 NH2
REMARK 500
REMARK 500 GEOMETRY AND STEREOCHEMISTRY
REMARK 500 SUBTOPIC: TORSION ANGLES
REMARK 500
REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS:
REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER;
REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE).
REMARK 500
REMARK 500 STANDARD TABLE:
REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2)
REMARK 500
REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI-
REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400
REMARK 500
REMARK 500 M RES CSSEQI PSI PHI
REMARK 500 ALA A 618 62.62 29.13
REMARK 500 ARG A 649 -15.27 82.36
REMARK 500 ASP A 650 42.90 -141.90
REMARK 500 ASP A 674 -66.75 -105.57
REMARK 500
REMARK 500 REMARK: NULL
REMARK 800
REMARK 800 SITE
REMARK 800 SITE_IDENTIFIER: AC1
REMARK 800 EVIDENCE_CODE: SOFTWARE
REMARK 800 SITE_DESCRIPTION: binding site for residue 31V A 801
REMARK 800
REMARK 800 SITE_IDENTIFIER: AC2
REMARK 800 EVIDENCE_CODE: SOFTWARE
REMARK 800 SITE_DESCRIPTION: binding site for residue GOL A 802
REMARK 800
REMARK 800 SITE_IDENTIFIER: AC3
REMARK 800 EVIDENCE_CODE: SOFTWARE
REMARK 800 SITE_DESCRIPTION: binding site for residue CL A 803
REMARK 800
REMARK 800 SITE_IDENTIFIER: AC4
REMARK 800 EVIDENCE_CODE: SOFTWARE
REMARK 800 SITE_DESCRIPTION: binding site for residue ACT A 804
REMARK 800
REMARK 800 SITE_IDENTIFIER: AC5
REMARK 800 EVIDENCE_CODE: SOFTWARE
REMARK 800 SITE_DESCRIPTION: binding site for residue ACT A 805
REMARK 800
REMARK 800 SITE_IDENTIFIER: AC6
REMARK 800 EVIDENCE_CODE: SOFTWARE
REMARK 800 SITE_DESCRIPTION: binding site for residue ACT A 806
REMARK 900
REMARK 900 RELATED ENTRIES
REMARK 900 RELATED ID: 4PMP RELATED DB: PDB
REMARK 900 RELATED ID: 4PMS RELATED DB: PDB
REMARK 900 RELATED ID: 4PMT RELATED DB: PDB
DBREF 4PMM A 501 787 UNP P04629 NTRK1_HUMAN 501 787
SEQADV 4PMM HIS A 788 UNP P04629 EXPRESSION TAG
SEQADV 4PMM HIS A 789 UNP P04629 EXPRESSION TAG
SEQADV 4PMM HIS A 790 UNP P04629 EXPRESSION TAG
SEQADV 4PMM HIS A 791 UNP P04629 EXPRESSION TAG
SEQRES 1 A 291 CYS VAL HIS HIS ILE LYS ARG ARG ASP ILE VAL LEU LYS
SEQRES 2 A 291 TRP GLU LEU GLY GLU GLY ALA PHE GLY LYS VAL PHE LEU
SEQRES 3 A 291 ALA GLU CYS HIS ASN LEU LEU PRO GLU GLN ASP LYS MET
SEQRES 4 A 291 LEU VAL ALA VAL LYS ALA LEU LYS GLU ALA SER GLU SER
SEQRES 5 A 291 ALA ARG GLN ASP PHE GLN ARG GLU ALA GLU LEU LEU THR
SEQRES 6 A 291 MET LEU GLN HIS GLN HIS ILE VAL ARG PHE PHE GLY VAL
SEQRES 7 A 291 CYS THR GLU GLY ARG PRO LEU LEU MET VAL PHE GLU TYR
SEQRES 8 A 291 MET ARG HIS GLY ASP LEU ASN ARG PHE LEU ARG SER HIS
SEQRES 9 A 291 GLY PRO ASP ALA LYS LEU LEU ALA GLY GLY GLU ASP VAL
SEQRES 10 A 291 ALA PRO GLY PRO LEU GLY LEU GLY GLN LEU LEU ALA VAL
SEQRES 11 A 291 ALA SER GLN VAL ALA ALA GLY MET VAL TYR LEU ALA GLY
SEQRES 12 A 291 LEU HIS PHE VAL HIS ARG ASP LEU ALA THR ARG ASN CYS
SEQRES 13 A 291 LEU VAL GLY GLN GLY LEU VAL VAL LYS ILE GLY ASP PHE
SEQRES 14 A 291 GLY MET SER ARG ASP ILE TYR SER THR ASP TYR TYR ARG
SEQRES 15 A 291 VAL GLY GLY ARG THR MET LEU PRO ILE ARG TRP MET PRO
SEQRES 16 A 291 PRO GLU SER ILE LEU TYR ARG LYS PHE THR THR GLU SER
SEQRES 17 A 291 ASP VAL TRP SER PHE GLY VAL VAL LEU TRP GLU ILE PHE
SEQRES 18 A 291 THR TYR GLY LYS GLN PRO TRP TYR GLN LEU SER ASN THR
SEQRES 19 A 291 GLU ALA ILE ASP CYS ILE THR GLN GLY ARG GLU LEU GLU
SEQRES 20 A 291 ARG PRO ARG ALA CYS PRO PRO GLU VAL TYR ALA ILE MET
SEQRES 21 A 291 ARG GLY CYS TRP GLN ARG GLU PRO GLN GLN ARG HIS SER
SEQRES 22 A 291 ILE LYS ASP VAL HIS ALA ARG LEU GLN ALA LEU ALA GLN
SEQRES 23 A 291 ALA HIS HIS HIS HIS
HET 31V A 801 37
HET GOL A 802 6
HET CL A 803 1
HET ACT A 804 4
HET ACT A 805 4
HET ACT A 806 4
HETNAM 31V N-(3-CYCLOPROPYL-1-PHENYL-1H-PYRAZOL-5-YL)-2-{4-[3-
HETNAM 2 31V METHOXY-4-(4-METHYL-1H-IMIDAZOL-1-YL)PHENYL]-1H-1,2,3-
HETNAM 3 31V TRIAZOL-1-YL}ACETAMIDE
HETNAM GOL GLYCEROL
HETNAM CL CHLORIDE ION
HETNAM ACT ACETATE ION
HETSYN GOL GLYCERIN; PROPANE-1,2,3-TRIOL
FORMUL 2 31V C27 H26 N8 O2
FORMUL 3 GOL C3 H8 O3
FORMUL 4 CL CL 1-
FORMUL 5 ACT 3(C2 H3 O2 1-)
FORMUL 8 HOH *146(H2 O)
HELIX 1 AA1 LYS A 506 ARG A 508 5 3
HELIX 2 AA2 ALA A 553 LEU A 567 1 15
HELIX 3 AA3 ASP A 596 HIS A 604 1 9
HELIX 4 AA4 ASP A 607 ALA A 612 1 6
HELIX 5 AA5 GLY A 623 LEU A 644 1 22
HELIX 6 AA6 ALA A 652 ARG A 654 5 3
HELIX 7 AA7 MET A 671 TYR A 676 1 6
HELIX 8 AA8 SER A 677 TYR A 680 5 4
HELIX 9 AA9 PRO A 690 MET A 694 5 5
HELIX 10 AB1 PRO A 695 ARG A 702 1 8
HELIX 11 AB2 THR A 705 THR A 722 1 18
HELIX 12 AB3 SER A 732 GLY A 743 1 12
HELIX 13 AB4 PRO A 753 TRP A 764 1 12
HELIX 14 AB5 GLU A 767 ARG A 771 5 5
HELIX 15 AB6 SER A 773 HIS A 789 1 17
SHEET 1 AA1 5 ILE A 510 GLU A 518 0
SHEET 2 AA1 5 GLY A 522 CYS A 529 -1 O VAL A 524 N GLY A 517
SHEET 3 AA1 5 MET A 539 LEU A 546 -1 O ALA A 545 N LYS A 523
SHEET 4 AA1 5 LEU A 586 GLU A 590 -1 O PHE A 589 N ALA A 542
SHEET 5 AA1 5 PHE A 575 CYS A 579 -1 N GLY A 577 O VAL A 588
SHEET 1 AA2 2 CYS A 656 GLY A 659 0
SHEET 2 AA2 2 VAL A 663 ILE A 666 -1 O VAL A 663 N GLY A 659
SHEET 1 AA3 2 TYR A 681 GLY A 684 0
SHEET 2 AA3 2 THR A 687 LEU A 689 -1 O LEU A 689 N TYR A 681
CISPEP 1 ARG A 583 PRO A 584 0 -0.79
SITE 1 AC1 15 ALA A 542 LYS A 544 GLU A 560 LEU A 563
SITE 2 AC1 15 LEU A 564 LEU A 567 PHE A 589 GLU A 590
SITE 3 AC1 15 TYR A 591 MET A 592 HIS A 648 LEU A 657
SITE 4 AC1 15 ASP A 668 PHE A 669 HOH A 917
SITE 1 AC2 3 PRO A 754 GLU A 755 HOH A 931
SITE 1 AC3 2 ARG A 761 HOH A 931
SITE 1 AC4 5 GLY A 625 ARG A 649 ARG A 702 HOH A 912
SITE 2 AC4 5 HOH A 922
SITE 1 AC5 5 ARG A 602 LYS A 725 GLN A 726 TYR A 729
SITE 2 AC5 5 HOH A1043
SITE 1 AC6 4 LYS A 725 TYR A 729 HOH A1038 HOH A1041
CRYST1 75.800 75.800 112.340 90.00 90.00 120.00 P 64 6
ORIGX1 1.000000 0.000000 0.000000 0.00000
ORIGX2 0.000000 1.000000 0.000000 0.00000
ORIGX3 0.000000 0.000000 1.000000 0.00000
SCALE1 0.013193 0.007617 0.000000 0.00000
SCALE2 0.000000 0.015234 0.000000 0.00000
SCALE3 0.000000 0.000000 0.008902 0.00000